{"id":76410,"date":"2018-02-27T23:22:52","date_gmt":"2018-02-28T07:22:52","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2018\/02\/precision-cancer-treatment-effective-in-treating-tumors"},"modified":"2018-02-27T23:22:52","modified_gmt":"2018-02-28T07:22:52","slug":"precision-cancer-treatment-effective-in-treating-tumors","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2018\/02\/precision-cancer-treatment-effective-in-treating-tumors","title":{"rendered":"Precision cancer treatment effective in treating tumors"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/precision-cancer-treatment-effective-in-treating-tumors.jpg\"><\/a><\/p>\n<p><em>Summary: Researchers who just finished a precision cancer treatment trial at Children\u2019s Hospital Los Angeles just reported that three out of four adult and child cancer patients responded favorably to a new precision therapy which targets a gene mutation. [<a href=\"http:\/\/longevityfacts.com\/precision-cancer-treatment-larotrectinib-treating-tumors\/\">This article<\/a> first appeared on <a href=\"http:\/\/longevityfacts.com\/about\/\">LongevityFacts<\/a>. Author: <a href=\"https:\/\/plus.google.com\/u\/0\/+BCHartman\">Brady Hartman.<\/a> ]<\/em><\/p>\n<p>Children\u2019s Hospital Los Angeles (CHLA) reports that three-fourths of adults and children with a variety of advanced cancers in different sites of the body responded to a novel therapy called larotrectinib that targets a specific genetic mutation.<\/p>\n<p>The researchers published the results of this phase 1\/2 trial on February 22, 2018, in the New England Journal of Medicine.<\/p>\n<p><!-- Link: <a href=\"http:\/\/longevityfacts.com\/precision-cancer-treatment-larotrectinib-treating-tumors\/\">http:\/\/longevityfacts.com\/precision-cancer-treatment-larotre...ng-tumors\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Summary: Researchers who just finished a precision cancer treatment trial at Children\u2019s Hospital Los Angeles just reported that three out of four adult and child cancer patients responded favorably to a new precision therapy which targets a gene mutation. [This article first appeared on LongevityFacts. Author: Brady Hartman. ] Children\u2019s Hospital Los Angeles (CHLA) reports [\u2026]<\/p>\n","protected":false},"author":446,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,269],"tags":[],"class_list":["post-76410","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/76410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/446"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=76410"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/76410\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=76410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=76410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=76410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}